Fri.Mar 28, 2025

article thumbnail

Prognostic implications of stress test-induced arrhythmias: a systematic review and meta-analysis

Open Heart

Background The significance of stress-test induced arrhythmias has been examined in prior studies, but there is no clear consensus regarding its significance. Objectives To determine the significance of stress test-induced arrhythmias. Methods Relevant studies examining arrhythmia in both exercise and pharmacological stress testing were searched for in PubMed, Embase and Cochrane databases from inception to 14 June 2023.

article thumbnail

Enhancing microcirculation in STEMI patients: can intracoronary thrombolysis combined with thrombus aspiration provide an optimal strategy?

Frontiers in Cardiovascular Medicine

ST-elevation myocardial infarction (STEMI) is a critical cardiovascular emergency characterized by acute coronary artery occlusion and subsequent myocardial injury. The current standard of care is primary percutaneous coronary intervention (PPCI), which aims to rapidly restore epicardial blood flow. However, despite successful revascularization, microvascular obstruction (MVO) remains a major challenge, contributing to adverse clinical outcomes.

article thumbnail

Resolving the observe zone: validation of the ESC 0/3-hour and the APACE criteria for NSTEMI triage

Open Heart

Background High-sensitivity cardiac troponin tests have enhanced early myocardial infarction diagnosis, yet many patients still land in the observe zone (OZ). Guidelines suggest a 3-hour troponin measurement for those in the European Society of Cardiology (ESC) 0/1 hour-algorithm’s OZ, but evidence on extended troponin testing times and their impact on diagnostic accuracy and outcomes remains sparse.

article thumbnail

Lipid metabolism-associated metabolites on cardiovascular diseases: a two-sample Mendelian randomized study

Frontiers in Cardiovascular Medicine

BackgroundThere is a growing body of evidence indicating that metabolites are associated with an increased risk of cardiovascular diseases (CVDs), the underlying causality of these associations remains largely unchallenged. Given the inherent difficulty in establishing causality using epidemiological data, we employed the technique of Mendelian randomization to investigate the potential role of plasma metabolite factors in influencing the risk of CVDs.MethodsThe exposure was based on 1,400 plasm

article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

Mavacamten maintenance dose determination: insights into individualised therapy for hypertrophic cardiomyopathy

Open Heart

Aims Mavacamten, the first approved myosin inhibitor for symptomatic obstructive hypertrophic cardiomyopathy (oHCM), addresses hypercontractility and left ventricular outflow tract (LVOT) obstruction. This study evaluates real-world experience with mavacamten, focusing on maintenance dose determination to optimise individual therapy and enhance patient safety.

article thumbnail

Long-Term Efficacy and Safety of JAK Inhibitors in Atopic Dermatitis

HCPLive

Experts discuss the long-term efficacy and safety of abrocitinib and upadacitinib in atopic dermatitis (AD), with sustained monotherapy results showing significant improvements in Investigator Global Assessment (IGA), Eczema Area and Severity Index (EASI), and Validated IGA-AD (vIGA-AD) scores. They also consider the safety profiles and potential risks, particularly in older patients, for long-term use of JAK inhibitors.

52

More Trending

article thumbnail

Early and mid-term outcomes of transcatheter closure of perimembranous ventricular septal defects using double-disc occluders

Frontiers in Cardiovascular Medicine

IntroductionVentricular septal defect (VSD) is a common congenital heart disease (CHD), accounting for 2030% of all CHD cases. While surgical closure has been the gold standard for treatment, transcatheter closure has emerged as a less invasive alternative, particularly for perimembranous VSDs. This study aimed to evaluate the early and mid-term outcomes of transcatheter closure using a double-disc occluder device in a single-center Vietnamese cohort.MethodA prospective descriptive study was con

VSD 52
article thumbnail

Introducing the 2025 Imaging for Impact Award to Recognize Imaging Team Excellence & Best Practices

Cassling

Founded in 1984, Casslings mission is to strengthen community healthcare. The company strives to bring innovative imaging solutions to communities and providers, so that patients and their families can live their best life. Thats why Cassling is excited to introduce a new awards program that recognizes and celebrates imaging teams contributions to keeping care local and improving patient outcomes.

article thumbnail

Enhancing member value and protecting the electrophysiology profession—Heart Rhythm Advocates are here

HeartRhythm

Advocacy is one of the key foundational missions of Heart Rhythm Society (HRS). Since its inception, HRS and its predecessor organizations have been able to provide the electrophysiology (EP) community the much needed assistance in various aspects of their professional activities. These efforts ranged from obtaining new codes for various procedures and aiding the American Medical Association in determining the appropriate value for these procedures.

article thumbnail

Stroke risk higher for at least a decade after minor stroke-like attacks, study indicates

Medical Xpress - Cardiology

The risk of a full-blown stroke will remain high for at least a decade after a person has a slight brush with stroke, in the form of a transient ischemic attack or minor stroke, a new study says.

Stroke 105
article thumbnail

MADIT II trial: A 2002 breakthrough in primary prevention of mortality with implantable cardioverter-defibrillator

HeartRhythm

The MADIT trial1 conducted between 1991 and 1996 was the first trial testing primary prevention of mortality with an implantable cardioverter-defibrillator (ICD). The study enrolled 196 patients randomized 1:1 to ICD vs no ICD and reported a 56% improvement in survival with an ICD in patients with coronary heart disease, reduced ventricular function, nonsustained ventricular tachycardia (VT), and inducible VT.

article thumbnail

RX Review: Understanding ATTR-CM's New Era of Management

HCPLive

In this video, part 1 of a 4-part series, panelists discuss recent advancements in ATTR-CM management.

97
article thumbnail

Finerenone and Atrial Fibrillation in Heart Failure

JAMA Cardiology

This secondary analysis of the Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients With Heart Failure (FINEARTS-HF) randomized clinical trial examines the efficacy and safety of finerenone in patients with heart failure with mildly reduced or preserved ejection fraction according to the presence and type of atrial fibrillation.

article thumbnail

Highly Educated People Face Steeper Cognitive Decline After Stroke

Med Page Today

(MedPage Today) -- Education level was associated with the trajectory of cognitive decline following stroke, an individual participant data meta-analysis of four U.S. cohort studies showed. After adjusting for pre-stroke cognition, college-educated.

article thumbnail

Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes

The New England Journal of Medicine

Among participants with type 2 diabetes and cardiovascular disease, chronic kidney disease, or both, oral semaglutide (14 mg) was associated with a lower risk of cardiovascular events than placebo after 4 years of follow-up.

article thumbnail

Future Cardiothoracic Surgeons Celebrate Match Day as 2025 Residency Match Breaks Records

Society of Thoracic Surgeons - Early Career

On Match Day, the 2025 Residency Match saw record participation with a 4.7% increase in applicants, and thoracic & vascular surgery reached a historic 100% fill rate.

article thumbnail

Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism

The New England Journal of Medicine

In a trial involving patients with active cancer and venous thromboembolism, extended anticoagulation with reduced-dose apixaban was noninferior to full-dose apixaban for preventing recurrent thromboembolic events.

Cancer 70
article thumbnail

Weight-Adjusted Waist Index Successfully Predicts Macular Degeneration

HCPLive

Study finds positive association between weight-adjusted waist index and risk of age-related macular degeneration in adults aged 40 or over.

66
article thumbnail

Anti-CD3 monoclonal antibody in treating patients with type 1 diabetes: an updated systematic review and meta-analysis

Cardiovascular Diabetology

To evaluate the efficacy of anti-CD3 monoclonal antibody (mAb) in patients with type 1 diabetes (T1D) and identify the influencing factors. Randomized controlled trials comparing anti-CD3 mAb with placebo or standard care in T1D participants were screened from PubMed, Embase, and Cochrane databases until 31 May 2024. Changes in area under the curve (AUC) of C-peptide, HbA1c level and daily insulin requirement were main outcomes.

article thumbnail

Fitusiran Approved for People With Hemophilia A or B, With and Without Inhibitors

HCPLive

Data from the phase 3 ATLAS trial supported Qfitlia's BLA, with the latest data presented at Decembers ASH meeting.

64
article thumbnail

Joint association of estimated glucose disposal rate and systemic inflammation response index with mortality in cardiovascular-kidney-metabolic syndrome stage 0–3: a nationwide prospective cohort study

Cardiovascular Diabetology

The Cardiovascular-Kidney-Metabolic (CKM) syndrome underscores the complex interactions among metabolic disorders, kidney disease, and cardiovascular conditions. Insulin resistance (IR) and inflammation are cr.

article thumbnail

FDA Issues CRL for Etripamil Nasal Spray (Cardamyst) in PSVT

HCPLive

Announced on March 28, 2025, the FDA's CRL to Milestone Pharmaceuticals cites CMC issues, but no issues with safety or efficacy data.

64
article thumbnail

Deciphering myocardial fibrosis: a comprehensive bibliometric analysis of mechanism over the period 1992–2023

Journal of Cardiothoracic Surgery

Myocardial fibrosis is a critical link in preventing the progression of heart disease. This study conducted a bibliometric analysis of its mechanism to identify trends and hotspots, aiming to provide valuable.

article thumbnail

Survey: Providers Prioritize QoL, Long-Term Care in BPD, Schizophrenia

HCPLive

A 2024 survey finds that most healthcare providers believe quality of life should be considered as much as symptom control when managing bipolar I disorder and schizophrenia.

article thumbnail

Oxidative stress and inflammation mediate the adverse effects of cadmium exposure on all-cause and cause-specific mortality in patients with diabetes and prediabetes

Cardiovascular Diabetology

The effect of cadmium exposure on mortality risk among individuals with diabetes and prediabetes remains unclear, particularly regarding potential mediation by oxidative stress and inflammation. This study aim.

article thumbnail

Dupilumab Effective for Atopic Dermatitis in Patients Aged 6 Months to 11 Years

HCPLive

These findings result from a systematic review and meta-analysis looking at the utilization of dupilumab among children and adolescents with atopic dermatitis.

59
article thumbnail

What is the relationship between Left atrial size and mitral “E” decceleration time ?

Dr. S. Venkatesan MD

I saw two patients recently, with a similar degree of hypertension and LVH. One with a normal-sized LA and the other with a mild LA enlargement. When checked for the “E” declaration time, it was found to be absolutely normal in the patient who had LAE. The one with normal LA size had a relatively short DT and his functional capacity was less. 52-year-old man with HT, and LVH with mild LAE.

article thumbnail

FDA Accepts Treprostinil Resubmission for PAH, PH-ILD Final Approval

HCPLive

Treprostinil (YUTREPIA) was previously granted tentative approval on August 16, 2024.

59
article thumbnail

Gasdermin D emerges as potential therapeutic target for atrial fibrillation

Medical Xpress - Cardiology

Atrial fibrillation (AF) is a common form of heart arrhythmia, a serious condition in which the heart beats so fast that its upper chambers, the atria, quiver. This irregular heartbeat can increase the risk of severe conditions, including heart failure, dementia and stroke.

article thumbnail

SAP-001 Demonstrates “Best in Class” Data for Gout With Hyperuricemia Refractory to SOC XOI Therapy

HCPLive

By 3 months, nearly all patients confirmed exposed to 30 or 60 mg SAP-001 reached serum uric acid levels below 6mg/dL.

52
article thumbnail

Aortic Stenosis — When Valve Intervention Is Not Enough

The New England Journal of Medicine

With the aging of the population, aortic stenosis affects a growing number of patients, with a prevalence of 12.4% among persons who are at least 75 years of age, among whom 3.4% have severe aortic stenosis.

article thumbnail

Brea's Patient Journey: Past Treatments and Experiences

HCPLive

A panelist discusses how they've tried various treatments for alopecia areata, including topical corticosteroids, intralesional steroid injections, immunotherapy, and Janus kinase inhibitors, with varying degrees of success in managing their condition, from temporary partial regrowth to more substantial and sustained hair restoration with newer targeted therapies.

52
article thumbnail

Growth of Multimodality Cardiac Imagers in the United States, 2013–2022

Circulation: Cardiovascular Imaging

Circulation: Cardiovascular Imaging, Ahead of Print.

article thumbnail

Brea's Patient Journey: Finding the Right Treatment Plan

HCPLive

A panelist discusses how Dr. Mostaghimi approached them about enrolling in a trial for deuruxolitinib for alopecia areata after conventional treatments failed, initially prompting questions about the drug's mechanism, potential adverse effects, trial protocol requirements, and realistic expectations for hair regrowth outcomes.

article thumbnail

FLAIR Vascular Hyperintensities as Imaging Biomarker in Pediatric Acute Ischemic Stroke

Stroke Journal

Stroke, Ahead of Print. BACKGROUND:Fluid-attenuated inversion recovery vascular hyperintensities (FVH) are high signal intensities on magnetic resonance imaging resulting from sluggish or stagnant flow through vessels. This investigation describes the prevalence, risk factors, and outcomes associated with FVH in pediatric arterial ischemic stroke (AIS).METHODS:Retrospective review of children aged 29 days to 18 years in a single institution stroke registry from 2006 to 2022 with AIS.

article thumbnail

Shifting Toward Multidisciplinary MASLD Care, with Christos Mantzoros, MD, DSc, PhD

HCPLive

Mantzoros explains factors contributing to the growing burden of MASLD and the need for collaboration between hepatology, primary care, and endocrinology.

52